Şerife TORUN, Berna BOTAN YILDIRIM, Çağrı KESİM, Aynur SÜNER, Özgür ÖZEN, Şule AKÇAY

Influenza viruses and SARS-CoV-2 in adult: ‘Similarities and differences’

Influenza viruses and SARS-CoV-2 in adult: ‘Similarities and differences’ Introduction: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing a global pandemic starting from December 2019, showed a course that resulted in serious mortality in the world. In order to understand SARSCoV-2 better, here we aimed to compare the similar and different characteristics of Influenza viruses occurring in the same season with SARS-CoV-2. Materials and Methods: A total of 144 patients (31 patients with COVID-19, 62 patients with H1N1 influenza, and 51 patients with influenza B) were included in the study. Demographic findings, chronic diseases, laboratory values, chest x-ray, and chest CT findings of the patients were evaluated retrospectively. Results: Median age of the COVID-19 patients and rate of male patients were higher than other patient groups (55 years; p< 0.001) (61% male; p< 0.001). The most common chronic medical conditions were hypertension and diabetes. Platelet numbers and alanine aminotransferase values were significantly higher in COVID-19 patients. Radiologically, bilateral (74.2%) and nonspecific distribution (58.1%), ground-glass opacities with consolidation (51.6%), patchy image (25.8%), ground-glass opacities with interstitial changes (22.6%) and halo sign (22.6%) were quite evident than other groups in COVID-19 patients (p< 0.05). Conclusion: We suggest that due to the higher PLT values observed in COVID-19 patients, initiation of anticoagulant therapy should be considered in the early stage and routine follow-up with d-dimer and fibrinogen should be applied for suspected patients. Moreover, attention should be paid in terms of possible liver toxicity of the drugs to be used in treatment due the higher ALT values observed in COVID-19 patients. Since we did not detect SARS-CoV-2 and influenza viruses concurrently in the same patient, it may be helpful to focus on only one virus in a patient with symptoms, and radiographic differences can be used to differentiate COVID-19 from influenza

PDF

___

1. Peteranderl C, Herold S, Schmoldt C. Human Influenza Virus Infections. Semin Respir Crit Care Med 2016; 37(4): 487-500.

2. Worldometer COVID-19 Data. Available from: https:// www.worldometers.info/coronavirus/

3. Han K, Zhu X, He F, Liu L, Zhang L, Ma H, et al. Lack of airborne transmission during the outbreak of pandemic (H1N1) 2009 among tour group members, China, June 2009. Emerg Infect Dis 2009; 15(10): 1578-81.

4. Centers for Disease Control and Prevention (CDC). H1N1 flu situation update 2009. Available from: www.cdc.gov/ hin 1flu

5. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) situation report–42. World Health Organization, Geneva 2020. Available from: https:// w w w . w h o . i n t / d o c s / d e f a u l t - s o u r c e / coronaviruse/20200302-sitrep-42-COVID-19.pdf?sfvrsn= d863e045_2. Accessed date: 3 March 2020.

6. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison t RT-PCR. Radiology 2020 Aug; 296(2): E115-E117.

7. Piroth L, Cottenet J, Mariet AS, Bonniaud P, Blot M, TubertBitter P, Quantin C. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med 2021 Mar; 9(3): 251-9.

8. Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 2020 Aug; 296(2): E46-E54.

9. Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020 Apr; 295(1): 202-7.

10. Hanny AS, Rebecca SKL, Walter HD, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020; 136(4): 489-500.

11. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and Clinical characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet 2020; 395(10223): 507-13.

12. Kline JA, Garrett JS, Sarmiento EJ, Strachan CC, Courtney DM. Over-testing for suspected pulmonary embolism in American emergency departments: The continuing epidemic. Circ Cardiovasc Qual Outcomes 2020; 13(1): e005753.

13. Schefold JC, Gerber JL, Angehrn MC, Muller M, Messmer AS, Leichtle AB. Renal function-adjusted D-dimer levels in critically ill patients with suspected thromboembolism. Crit Care Med 2020; 48(4): e270-e276.

14. Papic N, Pangercic A, Vargovic M, Barsic B, Vince A, Kuzman I. Liver involvement during influenza infection: perspective on the 2009 influenza pandemic. Influenza Other Respir Viruses 2012; 6(3):e2-5.

15. Tiegs G. Cellular and cytokine‐mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 2007; 45(1): 63-70.

16. Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, et al. Clinical Features of COVID-19-Related Liver Damage. Clin Gastroenterol Hepatol 2020; 18(7): 1561-6.

17. Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, et al. AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. AGA Gastroenterol 2020; S0016-5085(20)30593-X.

18. Gokturk B, Pekcan S, Guler S N, Artac H, Keles S, Kırac M. Efficacy of intravenous immunoglobulin treatment in immunocompromised children with H1N1 influenza: a clinical observation. Clin Respir J 2014; 10(2): 223-30.

19. Pediatric influenza: Practice Essentials, background, pathophysiology. Available at: http://emedicine.medscape.com/article/972269 overview#a7. Accessed on 27 Feb 2016.

20. Wang H, Wei R, Rao G, Zhu J, Song B. Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia. European Society of Radiology 2020; 22;1-8.

21. Yun H, Sun Z, Wu J, Tang A, Hu M, Xiang Z. Laboratory Data Analysis of Novel Coronavirus (COVID-19) Screening in 2510 Patients.Clin Chim Acta 2020; 18; 507: 94-7.

22. Huang Y, Tu M, Wang S, Wang S, Chen S, Zhou W, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis. Travel Med Infect Dis 2020; 101606.

23. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514-23.

24. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020; 1-7.

25. Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographics 2018; 38: 719-39.

26. Miller WT Jr, Mickus TJ, Barbosa E Jr, Mullin C, Van Deerlin VM, Shiley KT. CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections. AJR Am J Roentgenol 2011; 197: 1088-95.

27. Yuan Y, Tao XF, Shi YX, Liu SY, Chen JQ. Initial HRCT findings of novel influenza A (H1N1) infection. Influenza Other Respir Viruses 2012; 6: e114–e119.